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Bacterial glycogen is a polyglucose storage compound that is thought to prolong viability during stationary
phase. However, a speciﬁc role for glycogen has not been determined. We have characterized SMEG53, a
temperature-sensitive mutant of Mycobacterium smegmatis that contains a mutation in glgE, encoding a putative
glucanase. This mutation causes exponentially growing SMEG53 cells to stop growing at 42°C in response to
high levels of glycogen accumulation. The mutation in glgE is also associated with an altered growth rate and
colony morphology at permissive temperatures; the severity of these phenotypes correlates with the amount of
glycogen accumulated by the mutant. Suppression of the temperature-sensitive phenotype, via a decrease in
glycogen accumulation, is mediated by growth in certain media or multicopy expression of garA. The function
of GarA is unknown, but the presence of a forkhead-associated domain suggests that this protein is a member
of a serine-threonine kinase signal transduction pathway. Our results suggest that in M. smegmatis glycogen is
continuously synthesized and then degraded by GlgE throughout exponential growth. In turn, this constant
recycling of glycogen controls the downstream availability of carbon and energy. Thus, in addition to its
conventional storage role, glycogen may also serve as a carbon capacitor for glycolysis during the exponential
growth of M. smegmatis.
Glycogen is a polysaccharide composed of glucose in an
a-1,4-linked linear arrangement with a-1,6 branches. Bacterial
glycogen is generally considered a storage compound because
it accumulates in stationary phase and under growth-limiting
conditions (reviewed in reference 22). Presumably, glycogen
serves as a reservoir of carbon and energy during times of
starvation. Consistent with this idea, some bacterial mutants
unable to produce glycogen have decreased survival under
carbon starvation conditions relative to wild-type strains (22).
However, the particular physiological role of glycogen has not
been resolved. In bacteria such as Bacillus subtilis and Strepto-
myces coelicolor, glycogen synthesis is associated with sporula-
tion and may provide the resources necessary to drive differ-
entiation (10, 17, 19).
The genetic aspects of glycogen synthesis have been studied
intensively in Escherichia coli. Two glycogen-related gene clus-
ters, glgBX and glgCAP, have been characterized (reviewed in
reference 23). The genes glgC, glgA, and glgB encode the bio-
synthetic enzymes ADP-glucose pyrophosphorylase, glycogen
synthase, and branching enzyme, respectively, while glgP and
glgX encode the catabolic enzymes glycogen phosphorylase and
debranching enzyme, respectively (23, 28). A variety of growth-
limiting conditions, including low nitrogen, phosphate, or sul-
fur availability in the presence of excess carbon, promote gly-
cogen synthesis (22). Therefore, the amount of glycogen
accumulated by E. coli involves the integration of many phys-
iological signals, and accordingly, glycogen synthesis is a highly
regulated process. The global regulatory systems that control
glycogen synthesis include catabolite repression, the stringent
response, s
s, and csrA (23). Glycogen synthesis is also regu-
lated by the allosteric regulation of ADP-glucose pyrophos-
phorylase (23).
Earlier work done on mycobacterial glycogen suggested that
the features of glycogen accumulation in mycobacteria were
similar to those required for other bacteria (2–4, 13). However,
no detailed genetic or molecular studies pertaining to glycogen
have been reported. Here, we report the characterization of
SMEG53, a temperature-sensitive mutant of Mycobacterium
smegmatis that inappropriately accumulates glycogen during
exponential growth. The growth defect at 42°C is due to a
mutation in glgE, a glycogen-associated gene that encodes a
putative glucanase. The temperature-sensitive phenotype of
SMEG53 can be suppressed by the multicopy expression of
garA, a novel effector of glycogen accumulation, or by growth
on alternate media. The genetic and phenotypic data for
SMEG53 suggest that in M. smegmatis, carbon ﬂows preferen-
tially through a glycogen-recycling system prior to its use in
cellular biosynthesis and energy production.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and
plasmids used in these studies are given in Table 1. The M. smegmatis mc
2155
chromosomal DNA library was a gift from William Jacobs, Jr. (Albert Einstein
School of Medicine). The M. tuberculosis H37Rv chromosomal DNA library was
a gift from Julia Inamine (Colorado State University). The media used for
mycobacterial propagation were Middlebrook 7H9 and 7H10 with ADC supple-
ment (Difco, Detroit, MI). E. coli was grown in Luria broth (Difco, Detroit,
Mich.). Antibiotic concentrations were as follows: kanamycin, 10 (mycobacteria)
or (E. coli)2 5mg/ml; hygromycin, 100 mg/ml; and carbenicillin, 100 mg/ml.
Mutant generation. Chemical mutagenesis was performed by using a method
developed for Streptomyces (5), with some modiﬁcations. A culture of M. smeg-
matis mc
2155 was grown to mid-log phase (optical density at 600 nm [OD600] 5
0.8) at 37°C. Following adjustment of the culture pH to 8.5, nitrosoguanidine was
added to a ﬁnal concentration of 100 mg/ml. The cells were exposed to the
mutagen for 20 min with shaking at 37°C. Mutagenesis was stopped by centri-
fuging the cultures at 3,000 3 g for 10 min and removing the supernatant.
Following resuspension in fresh medium, the bacterial chromosomes were al-
lowed to segregate for4ha t30°C. Approximately 300 CFU of mutagenized
mycobacteria was spread on 7H10 containing 0.05% Tween 80 and then incu-
bated for 5 to 7 days at 30°C. Individual mutagenized colonies were evaluated for
temperature sensitivity at 42°C by replica plating using Accutran ﬁlters (Schlei-
cher & Schuell, Keene, N.H.). The colonies that were able to grow at 30°C but
not at 42°C were rescreened to conﬁrm the temperature-sensitive phenotype.
Genetic complementation. SMEG53 was electroporated with an M. smegmatis
mc
2155 or M. tuberculosis H37Rv extrachromosomal genomic library, using con-
ditions described previously (16). A proportion of the cells were plated at 30°C
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6670as an electroporation control, and the remainder were plated at 42°C. The
cosmid DNA from colonies able to grow at 42°C was recovered from SMEG53
by electroduction (6). The M. smegmatis genes restoring growth at 42°C to
SMEG53 were identiﬁed by ﬁrst constructing sublibraries of pAEB225 and
pAEB226. Cosmids were partially digested with Sau3AI, and fragments of 1 to 5
kb were ligated into the BamHI site of pMD30. SMEG53 was reelectroporated
with a pool of the resulting constructs followed by selection at 42°C. Subclones
able to complement SMEG53 were isolated by electroduction and then se-
quenced. The proportion of original cosmid constructs containing garA was
determined with PCR using the oligonucleotide primers 59-AAGACAGCAAT
TTGGGGG-39 (forward) and 59-ATGGGTCATCGGCTGTTC-39 (reverse).
The fragment was ampliﬁed with Pfu polymerase (Stratagene, La Jolla, Calif.)
according to the manufacturer’s speciﬁcations. The integrating plasmid contain-
ing garA was constructed by removing the insert DNA of pAEB234 with EcoRI
and XbaI digestion and then ligating this fragment into similarly digested
pMH94. The integrating plasmid containing glgE was constructed by removing
the insert DNA of pAEB235 with a KpnI and XbaI digestion, and then ligating
this fragment into similarly digested pMH94.
Sequence analysis. DNA constructs were sequenced with both vector- and
insert-speciﬁc primers, using an ABI310 automated sequencer with the Taq FS
dye-terminator ready reaction mix (Perkin-Elmer, Foster City, Calif.) according
to the manufacturer’s speciﬁcations. DNA sequences were assembled by using
the Sequencher package (GeneCodes, Ann Arbor, Mich.) and analyzed with
BLAST (1), PROSITE (15), CLUSTAL W (27), and McBoxshade version 2.11.
To determine the sequence of the SMEG53 glgE allele, the gene was ampliﬁed
by using primers 59-TTACTGACAAATCCCGCATCC-39 (forward) and 59-CT
GCTTCTCGTCATCTCGCC-39 (reverse). A single colony of SMEG53 was sus-
pended in 100 ml of water and then boiled for 5 min. One microliter of the boiled
cell mixture was used as the template DNA in the PCR. The DNA was ampliﬁed
with Pfu polymerase (Stratagene) according to the manufacturer’s speciﬁcations
in the presence of 2.5% dimethyl sulfoxide. The PCR product was isolated from
agarose gels and puriﬁed by using a gel extraction kit from Qiagen, Chatsworth,
Calif. This puriﬁed PCR product was then used in subsequent DNA sequencing
reactions.
Glycogen assays. Glycogen assays were performed on whole cells, using
a-amylase and glucose oxidation quantitation according to a previously pub-
lished protocol (21). Bacterial cells were grown under the appropriate conditions
to mid-log phase (OD600 5 0.75 to 0.85) or to saturation, harvested by centrif-
ugation at 3,000 3 g for 10 min, and then washed once in an equal volume of
water. The resulting cell pellet was stored at 280°C until required. For temper-
ature shift experiments, exponential-phase cells grown at 30°C were diluted to an
OD600 of approximately 0.3 in fresh medium and then grown at 42°C to an OD600
of 0.75 to 0.85.
Nucleotide sequence accession numbers. The DNA sequences of garA and
glgE derived from M. smegmatis mc
2155 have been deposited in GenBank under
accession no. AF173844 and AF172946, respectively.
RESULTS
Phenotypic characterization. Strain SMEG53 was originally
isolated as part of a temperature-sensitive mutant bank of M.
smegmatis mc
2155 that was generated by nitrosoguanidine mu-
tagenesis (7a). Besides temperature sensitivity, SMEG53 dis-
plays several other interesting phenotypic characteristics, in-
cluding an altered colony morphology (see below) and slightly
slower growth at the permissive temperature (Table 2). An-
other trait of SMEG53 is the suppression of the temperature-
sensitive phenotype when it is plated on certain growth media.
While SMEG53 is unable to grow at 42°C on 7H10, the me-
dium originally used for the isolation of the temperature-sen-
sitive mutants, it can form colonies when plated on M9 or
7H10 containing an osmolyte such as sucrose or NaCl (data not
shown). An interesting phenotype of SMEG53 is evident from
the growth curves performed on temperature-shifted cultures.
When an exponential-phase culture of SMEG53 is grown at
30°C and then shifted to 42°C, the culture doubles once and
then growth ceases. In contrast, the wild-type culture continues
to grow exponentially (Fig. 1). The temperature-dependent
growth cessation of SMEG53 is reversible, because when the
cells are shifted back to 30°C, growth resumes (data not
shown). Microscopic examination revealed that SMEG53 cells
that had stopped growing for several hours at 42°C were
shorter than actively growing mutant cells, which are the same
size as wild-type cells (data not shown). We also observed that
the growth cessation of SMEG53 at 42°C coincided with a
cellular clumping of the culture. These changes in cellular
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristics Reference
or source
M. smegmatis
mc
2155 ept1 glgE
1 25
SMEG53 ept1 glgE1(Ts) This study
E. coli XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F9 proAB lacI
qZDM15 Tn10 (Tet
r)] Stratagene
Plasmids
pMD30 Extrachromosomal E. coli-mycobacterial shuttle vector 12
pMH94 Mycobacterial integrating vector 18
pAEB225 M. smegmatis-derived cosmid containing garA This study
pAEB226 M. smegmatis-derived cosmid containing glgE This study
pAEB234 1.7-kb Sau3AI fragment containing garA cloned into pMD30 This study
pAEB235 2.4-kb Sau3AI fragment containing glgE cloned into pMD30 This study
pAEB236 EcoRI/XbaI insert fragment from pAEB234 cloned into pMH94 This study
pAEB237 M. tuberculosis-derived cosmid containing glgE This study
pAEB238 M. tuberculosis-derived cosmid containing glgE This study
pAEB239 KpnI/XbaI insert fragment of pAEB235 cloned into pMH94 This study
TABLE 2. Phenotypic characteristics of M. smegmatis mc
2155
and SMEG53
Strain Growth
temp (°C)
Growth
on 7H10
Glycogen
content
a
Doubling time
(h)
b
mc
2155 30 1 7.6 6 0.4 3.4 6 0.3 (1)
37 1 5.8 6 0.4 2.3 6 0.3 (1)
42 1 10.2 6 0.2 1.3 6 0.1 (1)
SMEG53 30 1 13.4 6 0.7 4.6 6 0.1 (0.7)
37 1 117.9 6 2.8 6.0 6 0.4 (0.4)
42 2
c 176.9 6 5.5 ND
d
a For glycogen determinations, bacterial cells were grown to an OD600 of 0.75
to 0.85 in 7H9 broth. For glycogen quantitation at 42°C, exponential cultures
grown at 30°C were diluted to an OD600 of 0.3 and then incubated at 42°C to an
OD600 of 0.75 to 0.85. Glycogen was quantitated as nanomoles of free glucose
liberated by a-amylase treatment per gram (wet weight) of cells. Each value
represents the mean of three assays 6 standard deviation.
b Calculated from exponential-phase cultures grown in 7H9. Relative growth
rates are shown in parentheses.
c SMEG53 can grow at 42°C on M9 and 7H9 containing 0.2 M NaCl.
d ND, a doubling time could not be accurately determined.
VOL. 181, 1999 GLYCOGEN RECYCLING IN M. SMEGMATIS 6671morphology and culture properties are similar to the changes
that occur in stationary-phase M. smegmatis cells, particularly
those starved for carbon (24). Since the molecular events as-
sociated with stationary phase in M. smegmatis have not been
characterized, we could not further demonstrate that the mu-
tant enters stationary phase at 42°C.
Genetic complementation. To identify the mutation that
causes the temperature-sensitive phenotype in SMEG53, we
electroporated the strain with an extrachromosomal M. smeg-
matis mc
2155 genomic DNA library and then selected for cos-
mids that could restore the ability of the mutant to grow at
42°C. Transformants able to grow at 42°C were recovered at a
frequency of 0.2%. Cosmid DNA was isolated from eight of
the colonies and then analyzed by restriction enzyme analysis.
Based on restriction enzyme patterns, it appeared that two
distinct genetic regions restored high-temperature growth to
SMEG53 (data not shown). To identify the speciﬁc genes in-
volved, sublibraries were constructed from two unrelated cos-
mids, pAEB225 and pAEB226, and then electroporated into
SMEG53. Subclones that restored wild-type growth to
SMEG53 at 42°C were isolated from each library. Subsequent
DNA sequence analysis of these clones revealed that two dif-
ferent genes restored the ability of SMEG53 to grow at 42°C.
One of the M. smegmatis genes that restores the ability of
SMEG53 to grow normally at 42°C is located on plasmid
pAEB235. This gene encodes a 78.2-kDa protein that is the
apparent homolog of Rv1327c, an M. tuberculosis protein with
similarity to glycosyl hydrolases of the a-amylase family (11).
The two proteins share an overall similarity of 79%, but the
Rv1327c gene product is 40 amino acids larger, the signiﬁcance
of which is unknown (Fig. 2). The M. smegmatis gene product
also shares 64% similarity with the Pep1 isoenzymes of S.
coelicolor (Fig. 2; reference 10). The pep1 genes are located in
a glycogen and trehalose biosynthetic cluster and appear to be
involved in polysaccharide catabolism. The genes encoding
Rv1327c and the M. smegmatis homolog are also closely linked
to genes involved in glycogen metabolism and catabolism. The
gene encoding Rv1327c is arranged in an operon with glgB, the
gene encoding glycogen branching enzyme, and is immediately
adjacent to glgP, the gene encoding glycogen phosphorylase.
This gene order has also been conserved in M. smegmatis (Fig.
3A). The similarity of the M. smegmatis gene product to po-
lysaccharide-degrading enzymes and its proximity to other gly-
cogen-associated genes suggest that this protein is involved in
glycogen catabolism. For this reason, and in view of other data
given below, we have designated this M. smegmatis gene glgE.
The second gene that restores the growth of SMEG53 at
42°C is located on plasmid pAEB234. This gene encodes a
16.6-kDa protein product with 89% overall similarity to the M.
tuberculosis protein Rv1827 (11) and 87% overall similarity to
the M. leprae protein MLCB1788.36c (accession no.
AL008609). The M. smegmatis gene product was predicted to
contain a forkhead-associated (FHA) domain (14) at amino
acid positions 76 to 125 when used in a search against the
PROSITE (15) database. This protein domain mediates the
recognition of a phosphorylated partner among members of
serine-threonine kinase signal transduction pathways (26). The
region corresponding to the FHA domain in the M. smegmatis
protein product contains the three invariant glycine, serine,
and histidine residues found in all FHA domain-containing
proteins (reference 26; Fig. 3B). Database searches using
BLAST also revealed that the M. smegmatis gene product has
similarity to several of the eukaryotic and bacterial proteins
originally used to deﬁne the FHA domain such as FraH, CDS1,
and KAPP (14) and other mycobacterial proteins that appar-
ently contain this protein motif such as EmbR (7). Another
feature of the predicted protein, with unknown signiﬁcance, is
an acidic N-terminal domain (12 of 75 amino acids are aspar-
tate or glutamate). In all three mycobacterial species, the gene
encoding the FHA domain-containing protein is the ﬁrst gene
in an operon with another gene of unknown function. The
protein product of the second gene has some similarity at the
N terminus to the MerR family of transcriptional activators,
but computer searches did not reveal a helix-turn-helix motif.
Upstream of the gene encoding the FHA domain-containing
protein is gcvH, a gene that encodes a protein involved in
glycine degradation (Fig. 3B). Given the regulatory role of
other proteins containing FHA domains, and our subsequent
ﬁndings detailed below, we will refer to the second M. smeg-
matis gene that restores high temperature growth to SMEG53
as garA (glycogen accumulation regulator).
Analysis of the eight original cosmids isolated during genetic
complementation studies using PCR and restriction enzyme
digestions revealed that two of the constructs contained garA
and the remaining six contained glgE (data not shown). Be-
cause the majority of the cosmids contained glgE, we looked
for the temperature-sensitive mutation in the SMEG53 allele
of this gene. Sequence analysis of the SMEG53 glgE allele
revealed that the temperature-sensitive mutant has a histidine-
to-tyrosine change at amino acid 349 of the protein product.
The histidine residue that is mutated in SMEG53 is conserved
in the M. tuberculosis Rv1327c protein and the S. coelicolor
Pep1 isozymes (Fig. 2). If glgE is the true complementing gene,
then the garA gene must act as a multicopy suppressor. To test
this hypothesis, garA and glgE were each cloned into an inte-
grating vector to create pAEB236 and pAEB239, respectively.
The resulting plasmids were then used to construct partial
diploids of SMEG53. Unlike pAEB234, the garA construct
made with an extrachromosomal vector, pAEB236 was unable
FIG. 1. Growth curves of SMEG53 and mc
2155 cultures at 30°C following a
temperature shift from 30 to 42°C. Cells grown exponentially at 30°C were
diluted to an OD600 of 0.3 in fresh medium; and then one half was incubated at
30°C, and the other half was incubated at 42°C. Cell densities were determined
at OD600 over the time period shown. Samples: SMEG53, 30°C (h); SMEG53,
42°C (n); mc
2155, 30°C (E); mc
2155, 42°C (F). Shown is a representative ex-
ample of three independent experiments. The time point where the morpholog-
ical change is ﬁrst noted in SMEG53 at 42°C is indicated by the symbol contain-
ing the asterisk.
6672 BELANGER AND HATFULL J. BACTERIOL.FIG. 2. Amino acid similarities between the M. smegmatis glgE gene product (SMEG), the M. tuberculosis homolog Rv1327c (TB), and one of the S. coelicolor pep1
gene products (PEP1). Alignments were performed with CLUSTAL W, and the amino acid shading was performed with McBoxshade version 2.11. Black shading
depicts amino acid residues conserved in all three of the proteins; grey shading depicts residues conserved in two. The histidine mutated in the SMEG53 glgE gene
product is indicated by the asterisk.
VOL. 181, 1999 GLYCOGEN RECYCLING IN M. SMEGMATIS 6673to restore normal growth to SMEG53 at 42°C. In contrast,
pAEB239 could restore wild-type growth to SMEG53 as well
as pAEB235, the glgE construct made with an extrachromo-
somal vector (data not shown). Thus, the temperature sensi-
tivity of SMEG53 is most likely attributable to the mutation in
the glycogen-associated gene glgE, and the growth defect
caused by this mutation can be suppressed by multiple copies
of garA.
To determine if any M. tuberculosis genes could restore the
growth of SMEG53 at 42°C, the mutant was also electropo-
rated with an extrachromosomal cosmid library of M. tubercu-
losis H37Rv. Following selection at 42°C, transformants that
could grow at the nonpermissive temperature were found to
occur at a frequency of 0.5%. The cosmids from 10 of these
colonies were isolated and analyzed by restriction enzyme
analysis. The restriction patterns obtained for these constructs
indicated that all 10 cosmids represented a single genetic re-
gion (data not shown). The DNA sequence was determined at
either end of the cosmid insert for the constructs pAEB237
and pAEB238. Database searches with this partial sequence
information enabled us to map the location of the cosmid
inserts within the genome sequence of M. tuberculosis H37Rv.
The DNA region common to the cosmids examined was found
to contain the Rv1327c gene, the M. tuberculosis glgE homolog.
The M. tuberculosis H37Rv garA homolog, Rv1827, is located
elsewhere on the chromosome and is not present in these DNA
constructs. Thus, the complementation and genetic studies
suggest that the M. tuberculosis Rv1327c gene product can
functionally substitute for the M. smegmatis glgE gene product.
SMEG53 accumulates glycogen in a temperature-dependent
manner. The identiﬁcation of the H349Y mutation in the
SMEG53 glgE gene product suggested that a perturbation in
glycogen levels may be responsible for the temperature-sensi-
tive phenotype of this strain. Therefore, we examined the gly-
cogen content of wild-type and SMEG53 exponential-phase
cells grown at various temperatures. At the permissive temper-
ature of 30°C, SMEG53 accumulated approximately twofold
more glycogen than the wild-type cells (Table 2). Mutant cells
grown at 37°C, a temperature that is permissive for SMEG53
growth, accumulated 20-fold more glycogen than wild-type
cells treated similarly (Table 2). Cells that were grown expo-
nentially at 30°C and then shifted to 42°C were also examined
for glycogen accumulation. For these studies, the SMEG53
cells were incubated at 42°C until the optical density of the
culture no longer increased. Under these conditions, SMEG53
cells accumulated approximately 18-fold more glycogen than
the wild-type cells (Table 2). It is noteworthy that both the
mutant and the wild type accumulated glycogen in a temper-
ature-dependent manner. Therefore, while the ratio of glyco-
gen accumulation between SMEG53 and the wild-type are
similar at 37 and 42°C, the absolute level of glycogen accumu-
lation is highest in the mutant at 42°C (Table 2). We also
examined the glycogen content of stationary-phase SMEG53
and wild-type cells grown at 30°C. At this temperature, the
overall growth dynamics of both strains are similar, and they
reach saturation at the same optical density. In stationary
phase, SMEG53 and the wild-type contain similar levels of
glycogen (15.6 6 2.1 and 15.0 6 0.8, respectively, nmol of free
glucose liberated per g of cells). Taken together, these data are
consistent with the idea that the H349Y mutation in the glgE
gene product of SMEG53 results in a temperature-dependent
accumulation of glycogen in this strain during exponential
growth. Presumably, with the putative degradative role of
GlgE impaired, glycogen synthesis continues unchecked in ac-
tively growing SMEG53 cells, and the growth of the mutant
ceases. The fact that glycogen can accumulate in SMEG53
implies that there is a continuous synthesis and breakdown of
glycogen in actively growing M. smegmatis cells under normal
culture conditions.
Growth of SMEG53 is restored by suppression of glycogen
accumulation. Our data are consistent with the idea that the
temperature sensitivity of SMEG53 results from insufﬁcient
GlgE-mediated glycogen degradation. If this hypothesis is true,
then the restoration of growth to SMEG53 at 42°C by glgE
should be accompanied by near-normal levels of glycogen.
Indeed, at the nonpermissive temperature the glycogen con-
tent of SMEG53 cells containing a plasmid-encoded wild-type
copy of glgE was signiﬁcantly lower than that of mutant cells
containing only the cloning vector (Fig. 4A).
Several conditions were found to suppress the temperature
sensitivity of SMEG53 but not the differences in growth rate or
colony morphology. One of these conditions was the multicopy
expression of the garA gene. To better understand why sup-
pression occurs, we compared the glycogen content at 42°C of
SMEG53 cells containing an extrachromosomal copy of garA
with that of cells carrying the vector alone. The glycogen con-
tent of SMEG53 cells overexpressing garA was approximately
1.5-fold lower than that found in cells containing only the
cloning vector (Fig. 4A). Although lower, the glycogen content
of cells containing garA was still approximately sixfold higher
than that of cells containing an extrachromosomal copy of glgE
(Fig. 4A). These results indicate that suppression by garA does
not arise from tolerance of high glycogen levels. Rather, sup-
pression occurs because the amount of accumulated glycogen
falls below a putative threshold level associated with growth
cessation. The glycogen content of SMEG53 cells grown at the
nonpermissive temperature in 7H9 containing 0.2 M NaCl or
M9 was also examined. The glycogen levels of SMEG53 cells
grown in M9 or 7H9 containing 0.2 M NaCl at 42°C were two-
and threefold lower, respectively, than the glycogen levels
found previously in mutant cells grown in 7H9 at 42°C (Fig.
FIG. 3. Genetic organization of the SMEG53 complementing genes glgE (A)
and garA (B). The region shown depicts the smallest amount of DNA required
for the restoration of high-temperature growth to SMEG53 based on subclone
insert size or overlapping clone analysis. Shadings denote complete (black) and
partial (shaded) open reading frames. Arrows indicate direction of transcription,
and lines depict intervening DNA. Also shown is the putative gene product of
garA. The FHA domain predicted by PROSITE is boxed, and the three invariant
amino acid residues associated with this domain are shown in bold.
6674 BELANGER AND HATFULL J. BACTERIOL.4B). Thus, the mechanism of suppression appears to be the
same for SMEG53 cells grown in these alternate media and
mutant cells overexpressing garA.
Glycogen accumulation is responsible for altered growth
rates and morphology. As noted above, SMEG53 concomi-
tantly accumulates almost twofold more glycogen and grows at
approximately 70% of the rate of the wild-type strain at 30°C.
To demonstrate that it is the increase in glycogen accumulation
that inﬂuences the growth rate of SMEG53, we determined the
doubling times of the mutant and wild-type cells grown at 37°C.
As previously established, SMEG53 cells accumulate approxi-
mately 20-fold more glycogen than the wild-type cells at this
temperature. If glycogen does adversely affect growth rate,
then the mutant should grow even more slowly than the wild
type at 37°C than it does at 30°C. The doubling time of the
wild-type strain decreases as the growth temperature increased
from 30 to 37°C, but the doubling time of the mutant actually
increases at the higher temperature (Table 2). Comparison of
the growth rates showed that the SMEG53 cells grow at only
40% of the rate of the wild-type cells at 37°C (Table 2). Thus,
as the glycogen levels of SMEG53 increase, the growth rate of
the strain decreases.
As mentioned earlier, SMEG53 exhibits an altered colony
morphology at the permissive temperature. In comparison with
the wild-type colonies, SMEG53 colonies grown at 30°C ap-
pear slightly transparent with irregular borders (Fig. 5A and
B). To demonstrate that glycogen accumulation in exponential
phase correlates with colony morphology, we examined
SMEG53 cells containing either glgE or garA grown at 42°C.
Since mutant cells containing glgE have low levels of glycogen
at the nonpermissive temperature, we would expect the colony
morphology of these cells to be indistinguishable from the
wild-type cell morphology. This was indeed the case (Fig. 5C).
Conversely, as we had previously demonstrated, SMEG53 cells
transformed with garA and grown at 42°C still contain approx-
imately six times more glycogen than mutant cells containing
glgE and grown at 42°C. Therefore, if glycogen accumulation
inﬂuences colony morphology, we would expect these cells to
show a more pronounced change in morphology in comparison
with SMEG53 cells containing glgE grown at 42°C. As ex-
pected, SMEG53 transformed with garA and grown at 42°C did
exhibit a more dramatic morphology change (Fig. 5D). garA
did not produce such a morphology change at 42°C when
electroporated into the wild-type strain (data not shown).
Since mycobacterial colony morphology is inﬂuenced by the
composition of the cell wall (8, 9, 20), these observations sug-
gest that the accumulation of glycogen in SMEG53 affects cell
wall biosynthesis.
DISCUSSION
The work reported here has revealed several exciting new
aspects of glycogen synthesis in M. smegmatis. The ﬁnding that
the temperature-sensitive mutant SMEG53 accumulates high
levels of glycogen suggests that the polysaccharide is being
constantly synthesized and then recycled by GlgE throughout
exponential growth. Therefore, the absolute levels of glycogen
present in exponential-phase M. smegmatis cells represents a
net accumulation of polysaccharide that results from coordi-
nated synthesis and degradation. These results contradict the
commonly accepted ideas that in bacteria, glycogen levels re-
ﬂect only the synthetic capabilities of the cell and glycogen
degradation occurs exclusively in stationary phase (22, 23). In
E. coli, the genes encoding proteins with both glycogen cata-
bolic and metabolic functions may be found located in the
same operon (23). In M. smegmatis, glgE, a gene encoding a
protein with a predicted role in glycogen catabolism, is in an
operon with glgB. This type of genetic arrangement is consis-
tent with the idea that the metabolic and catabolic enzymes
associated with glycogen are coordinately expressed and that
the gene products work in concert as a single biological pro-
cess. Though the absolute levels varied, SMEG53 accumulated
high levels of glycogen at 42°C under all growth conditions
tested. This suggests that glycogen synthesis and recycling con-
FIG. 4. Glycogen content of SMEG53 grown under conditions suppressing
the temperature-sensitive phenotype. Exponentially growing cultures were di-
luted to an OD600 of 0.3 in fresh medium and then shifted to 42°C. Cells were
grown to mid-log phase (OD600 5 0.75 to 0.85), and then glycogen assays
performed as before. Each value represents the mean of three assays 6 standard
deviation. (A) Mutant cells containing pMD30, pAEB234 (garA), or pAEB235
(glgE), grown in 7H9 containing 10 mg of kanamycin per ml. (B) SMEG53 cells
grown in 7H9, 7H9 containing 0.2 M NaCl (NaCl), or M9.
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during normal growth.
The phenotype of SMEG53 suggests that glycogen accumu-
lation coincides with a limited availability of carbon and energy
in the cell. At 30°C, approximately twofold more glycogen accu-
mulates in SMEG53 in comparison to the wild type, and slower
growth and an altered colony morphology are observed. At
42°C, glycogen accumulation is 18-fold higher than in the wild
type, and the growth of the mutant cannot be sustained. One
model that explains these results is that during normal growth,
wild-type M. smegmatis preferentially shunts its available car-
bon into glycogen synthesis prior to using it in metabolism. In
SMEG53, the mutation in GlgE interferes with normal glyco-
gen recycling, glucose remains sequestered in glycogen, and
the downstream utilization of carbon is compromised. This
model is based on the phenotypes observed in SMEG53 during
growth in 7H9, a medium that supports the optimal growth of
M. smegmatis in vitro. However, a reasonable assumption is
that if this type of carbon processing occurs in 7H9, then it may
be an intrinsic process that occurs in the cell under all growth
conditions. We have observed that under certain growth con-
ditions, including growth in M9 or 7H9 containing 0.2 M NaCl
or growth while overexpressing garA, SMEG53 still exhibits
high levels of glycogen accumulation, slow growth, and altered
colony morphologies but does not stop growing at 42°C. Ac-
cording to our carbon utilization model, glycogen recycling
must occur in order for there to be enough carbon for growth.
Therefore, one possibility is that the temperature-sensitive
phenotype of SMEG53 can be suppressed because the speciﬁc
growth conditions somehow promote glycogen recycling de-
spite the mutation in GlgE. The growth of M. smegmatis in M9
and 7H9 containing 0.2 M NaCl is slower than it is in 7H9 at
all temperatures. While comparisons cannot be made at 42°C,
SMEG53 also grows slower in these media than it does in 7H9
at 30°C. It is tempting to speculate that suppression occurs in
the mutant because the slow growth is associated with an
alternate form of glycogen recycling in M. smegmatis. If so, we
would expect that under growth-limiting conditions, M. smeg-
matis and perhaps other mycobacteria would accumulate low
levels of glycogen. However, it has been well established that
just the opposite is true: under growth-limiting conditions,
mycobacteria accumulate higher levels of glycogen (2–4, 13).
In view of this, we favor the hypothesis that slow growth spe-
ciﬁcally inﬂuences glycogen recycling in SMEG53 by lowering
the demand for carbon by the cell, thereby creating a condition
where the impaired enzymatic activity of the mutated GlgE
enzyme can release enough glucose from glycogen to sustain
growth. We have observed that SMEG53 cells containing mul-
tiple copies of garA grow slower than mutant cells containing
either the cloning vector or plasmid-encoded glgE at the per-
missive temperature. Thus, similar molecular mechanisms of
suppression may be operating in SMEG53 cells overexpressing
garA and mutant cells grown in alternate media.
The precise role of glgE and garA in the glycogen synthesis
and recycling pathway remains to be determined. In E. coli,
glgX, the gene encoding glycogen debranching enzyme, is lo-
cated in an operon with glgB, the gene encoding glycogen
branching enzyme (23). While glgE is located in an operon with
FIG. 5. (A and B) Colonial morphology of wild-type (A) and SMEG53 (B) colonies grown at 30°C on 7H10. (C and D) Colonies of SMEG53 complemented with
pAEB235 (glgE; C) or pAEB234 (garA; D) and grown at 42°C on 7H10. The colonies shown in panel A are representative of the morphology found for the wild-type
under all conditions tested.
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tative homolog of GlgX is encoded by Rv1564c, a gene located
elsewhere in the chromosome (11). Additional studies are
needed to determine the role that GlgE fulﬁlls in glycogen
catabolism. The garA gene product is a novel effector of gly-
cogen accumulation. The presence of an FHA domain in GarA
suggests that this protein is a member of a serine-threonine
kinase signal transduction pathway. Analysis of the M. tuber-
culosis genome sequence indicates that this organism uses
serine-threonine kinase signal transduction pathways, but the
cellular processes controlled by these regulatory pathways are
unknown (11). Further studies with garA and SMEG53 may
provide valuable information about the role of serine-threo-
nine kinase signal transduction pathways in mycobacteria.
Why synthesize glycogen and then recycle it during expo-
nential phase? Our data for SMEG53 are best explained by the
idea that glycogen acts as a carbon capacitor for glycolysis
during the exponential growth of M. smegmatis. In this model,
carbon that is not immediately required for glycolysis would be
temporarily stored in glycogen and then accessed when needed
by glycogen recycling. Such a system would modulate the ﬂow
of carbon into glycolysis and prevent a wasteful expenditure of
resources. Glycogen is an ideal carbon capacitor for glycolysis
because the two processes are linked by their requirement for
glucose-6-phosphate. In the case of glycogen synthesis, glu-
cose-6-phosphate is required for the production of glucose-1-
phosphate, which is subsequently used in ADP-glucose forma-
tion (22, 23). Using the carbon capacitor model, we predict
that the conditions favoring a high rate of glycolysis would also
favor a high rate of glycogen synthesis. This idea could account
for the allosteric activation of ADP-glucose pyrophosphorylase
in M. smegmatis by the glycolytic intermediates fructose-1-
phosphate and fructose-1,6-bisphosphate (13). The carbon ca-
pacitor model also predicts that under conditions where the
rate of glycolysis, and therefore the demand for glucose, is low,
glycogen recycling should also be low. This idea could explain
the accumulation of glycogen under nutrient-limiting condi-
tions and in stationary phase (2–4, 13). Under these conditions,
the cell would want to limit the ﬂow of carbon through glyco-
lysis, so more of the carbon would remain stored in glycogen.
The identiﬁcation of an exponential-phase glycogen synthe-
sis and recycling system in M. smegmatis raises the question of
whether other bacteria have such a system. Mutants of E. coli
that produce no glycogen or make excessive amounts of the
polysaccharide have been isolated, but such mutants grow nor-
mally in comparison to the wild type (22, 23). The defects in
glycogen accumulation are attributed to decreased or in-
creased biosynthetic capabilities (22, 23). These studies do not
preclude the existence of an exponential-phase glycogen syn-
thesis and recycling system since mutants in genes encoding
glycogen-degrading enzymes have not been studied. It is pos-
sible that in E. coli, a disruption in a gene such as glgX or
another amylolytic enzyme-encoding gene, coupled with the
appropriate growth conditions, could produce a phenotype
similar to that observed in SMEG53. Further studies should
determine if exponential-phase glycogen synthesis and recy-
cling is unique to mycobacteria or is a common theme in
bacteria.
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